{
    "eid": "2-s2.0-85053010803",
    "title": "Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWG",
    "cover-date": "2018-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Cytogenetic risks",
        "Induction treatment",
        "Performance status",
        "Senility",
        "Thailand"
    ],
    "authors": [
        "Weerapat Owattanapanich",
        "Eakkapol Utchariyaprasit",
        "Adisak Tantiworawit",
        "Ekarat Rattarittamrong",
        "Pimjai Niparuck",
        "Teeraya Puavilai",
        "Jakrawadee Julamanee",
        "Pirun Saelue",
        "Chantiya Chanswangphuwana",
        "Chantana Polprasert",
        "Wasithep Limvorapitak",
        "Nonglak Kanitsap",
        "Chinadol Wanitpongpun",
        "Chajchawan Nakhakes",
        "Chantarapa Sriswasdi",
        "Kannadit Prayongratana"
    ],
    "citedby-count": 6,
    "ref-count": 22,
    "ref-list": [
        "Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California",
        "North American leukemia, intergroup phase III randomized trial of single agent clofarabine as induction and post-remission therapy, and decitabine as maintenance therapy in newly diagnosed acute myeloid leukemia in older adults (age \u226560 years): a trial of the ECOG-ACRIN Cancer Research Group (E2906)",
        "Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry",
        "Age and acute myeloid leukemia",
        "International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts",
        "Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia",
        "Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia",
        "Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML",
        "Acute myeloid leukemia in the elderly: therapeutic options and choice",
        "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia",
        "Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel",
        "Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction",
        "Acute myeloid leukemia and myelodysplastic syndromes in older patients",
        "Cytogenetic and genetic mutation features of de novo acute myeloid leukemia in elderly Chinese patients",
        "The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial",
        "A single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia\u2014evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients",
        "Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases",
        "A multicenter, retrospective analysis of elderly patients with acute myeloid leukemia who were treated with decitabine",
        "Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia",
        "Patterns of care and survival for elderly acute myeloid leukemia\u2014challenges and opportunities",
        "Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients",
        "Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60013939",
            "affilname": "Faculty of Medicine, Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013939",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60011189",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Siriraj Clinical Research Center",
        "Thai Society of Hematology"
    ]
}